| 1 |
Guideline Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. 2008
FitzSimons D, François G, De Carli G, Shouval D, Prüss-Ustün A, Puro V, Williams I, Lavanchy D, De Schryver A, Kopka A, Ncube F, Ippolito G, Van Damme P. · World Health Organization, Geneva, Switzerland. · Occup Environ Med. · Pubmed #18562683 No free full text.
Abstract: The Viral Hepatitis Prevention Board (VHPB) convened a meeting of international experts from the public and private sectors in order to review and evaluate the epidemiology of blood-borne infections in healthcare workers, to evaluate the transmission of hepatitis B and C viruses as an occupational risk, to discuss primary and secondary prevention measures and to review recommendations for infected healthcare workers and (para)medical students. This VHPB meeting outlined a number of recommendations for the prevention and control of viral hepatitis in the following domains: application of standard precautions, panels for counselling infected healthcare workers and patients, hepatitis B vaccination, restrictions on the practice of exposure-prone procedures by infected healthcare workers, ethical and legal issues, assessment of risk and costs, priority setting by individual countries and the role of the VHPB. Participants also identified a number of terms that need harmonization or standardisation in order to facilitate communication between experts.
|
| 2 |
Article Prevention of viral hepatitis in Italy. 2004
FitzSimons D, François G, Bonanni P, Mele A, Zanetti A, Stroffolini T, Crovari P, Van Damme P. · World Health Organization, 1211 Geneva, Switzerland. · Vaccine. · Pubmed #15364461 No free full text.
Abstract: The overall situation on viral hepatitis prevention and control in Italy was reviewed and evaluated at a Viral Hepatitis Prevention Board (VHPB) meeting in Catania, Sicily, on 7-8 November 2002. Several specific conclusions, drawn from the presentations and discussions, were considered to constitute an example of how to handle these issues in other European and industrialized countries.
|
| 3 |
Article Combined hepatitis B vaccines. 2003
FitzSimons D, François G, Emiroğlu N, Van Damme P. · World Health Organization, Via Appia 20, 1211 Geneva, Switzerland. · Vaccine. · Pubmed #12615425 No free full text.
Abstract: The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed. Data on the safety, immunogenicity, and European licensing status and availability of haxavalent vaccines combining hepatitis B (HepB), Haemophilus influenza type b (Hib), diphtheria, tetanus, and pertussis (acellular) (DTPa), and inactivated poliovirus (IPV) antigens were presented. Finally, the impact of the availability of combined hepatitis B vaccines on hepatitis B immunisation programmes in Europe were examined and the added value of combined hepatitis B vaccines globally was estimated.
|
| 4 |
Minor Prevention and control of viral hepatitis through adolescent health programmes in Europe. 2007
FitzSimons D, Vorsters A, Hoppenbrouwers K, Van Damme P, Anonymous00442, Anonymous00443. · World Health Organization, Via Appia 20, CH-1211 Geneva, Switzerland. · Vaccine. · Pubmed #18036709 No free full text.
Abstract: The Viral Hepatitis Prevention Board jointly organized with the European Union for School and University Health and Medicine a meeting on the prevention and control of viral hepatitis through adolescent health programmes in Europe, held in Ljubljana, Slovenia, 15-16 March 2007. Participants from some 16 countries in Europe as well as the United States of America emphasized the importance of reaching adolescents mainly through school health programmes, provided an overview of currently existing youth health systems and reviewed their experiences with childhood and adolescent immunization programmes. The meeting concluded with a discussion of issues, lessons learnt, opportunities and action points for the future.
|
| 5 |
Minor Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the newly independent states. 2002
FitzSimons D, Van Damme P, Emiroglu N, Godal T, Kane M, Malyavin A, Margolis H, Meheus A. · Viral Hepatitis Prevention Board, University of Antwerp, Antwerp, Belgium. · Vaccine. · Pubmed #11858851 No free full text.
This publication has no abstract.
|
|
|